The findings presented in this study provide valuable insight into some possible molecular mechanisms of epileptogenesis and identify GAP-43 as a potential new target protein for the treatment and prevention of epilepsy in cortical dysplasia. This evidence concerns the gene GAP43 and epilepsy.